synphasic
norethisterone; ethinyloestradiol -
levlen ed
bayer australia ltd - levonorgestrel; ethinyloestradiol -
microgynon 50 ed
bayer australia ltd - levonorgestrel; ethinyloestradiol -
logynon ed
bayer australia ltd - levonorgestrel; ethinyloestradiol -
yasmin
bayer australia ltd - drospirenone; ethinyloestradiol -
laila-35 ed
aspen pharma pty ltd - cyproterone acetate; ethinyloestradiol -
estelle-35 ed
actavis pty ltd - ethinyloestradiol; cyproterone acetate -
jene-35 ed
eris pharmaceuticals (australia) pty ltd - ethinyloestradiol; cyproterone acetate -
brooke drospirenone/ethinyloestradiol 3 mg/20 microgram tablet blister composite pack
alphapharm pty ltd - ethinylestradiol, quantity: 0.02 mg; drospirenone, quantity: 3 mg - tablet - excipient ingredients: polacrilin potassium; magnesium stearate; lactose monohydrate - drospirenone/ethinyloestradiol-alphapharm 3/20 is indicated for use as: ? an oral contraceptive. ? treatment of moderate acne vulgaris in women who seek oral contraception ? treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of drospirenone 3 mg/ethinyloestradiol 20 ?g tablets for pmdd was not assessed beyond 3 cycles. drospirenone 3 mg/ethinyloestradiol 20 ?g tablets has not been evaluated for treatment of pms (premenstrual syndrome) (see clinical trials).
zaida 3/20 drospirenone/ethinyloestradiol 3 mg/20 microgram tablet blister composite pack
alphapharm pty ltd - drospirenone, quantity: 3 mg; ethinylestradiol, quantity: 0.02 mg - tablet - excipient ingredients: polacrilin potassium; lactose monohydrate; magnesium stearate - zaida 3/20 is indicated for use as: ? an oral contraceptive. ? treatment of moderate acne vulgaris in women who seek oral contraception ? treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of drospirenone 3 mg/ethinyloestradiol 20 ?g tablets for pmdd was not assessed beyond 3 cycles. drospirenone 3 mg/ethinyloestradiol 20 ?g tablets has not been evaluated for treatment of pms (premenstrual syndrome) (see clinical trials).